Women's Imaging Guide | WellAlly

Quick Answer: Women have unique imaging needs throughout their lives, with breast cancer screening and pelvic imaging being the most common concerns. Mammography remains the cornerstone of breast cancer screening, recommended annually starting at age 40 for average-risk women (or earlier based on risk factors). Women with dense breasts may benefit from supplemental screening with breast ultrasound or MRI, which can detect cancers missed on mammograms. For pelvic imaging, ultrasound is the first choice for evaluating gynecologic concerns—fibroids, ovarian cysts, pelvic pain, and abnormal bleeding—using no radiation. MRI provides detailed evaluation of complex conditions like endometriosis, adenomyosis, and cancer staging. Understanding which imaging test is appropriate for your situation, age, and risk factors ensures you receive the right test at the right time.

Women's imaging has evolved dramatically, with personalized screening approaches and advanced technologies that detect disease earlier while minimizing unnecessary testing and radiation exposure.

Mammography: The Gold Standard

What mammography is:

• Low-dose X-ray of breast tissue
• Two views per breast: Craniocaudal (top-to-bottom) and mediolateral oblique (angled)
• Digital technology: Modern digital mammography provides better images than film
• 3D mammography (tomosynthesis): Creates slice-by-slice images of breast tissue

Screening recommendations (average-risk women):

High-risk screening (women with BRCA mutations, strong family history, prior chest radiation):

• Annual mammogram starting at age 25-30 (10 years before earliest family cancer)
• Annual breast MRI (supplemental to mammogram)
• Consider breast ultrasound if MRI unavailable

3D mammography (tomosynthesis) benefits:

• More accurate detection: Finds 1-2 more cancers per 1,000 women screened
• Fewer false positives: Reduces call-backs for additional imaging
• Better visualization: Especially helpful for dense breasts
• Increasingly available: Most modern breast centers now offer tomosynthesis

Dense Breasts and Supplemental Screening

What are dense breasts?:

• Fibroglandular tissue: More glandular and fibrous tissue, less fatty tissue
• Mammogram appearance: Dense tissue appears white (same as cancer)
• Common: About 50% of women have heterogeneously dense or extremely dense breasts
• Risk factor: Dense breasts increase breast cancer risk 4-6x

The density dilemma:

• Masking effect: Dense tissue can hide cancers on mammogram (both appear white)
• Increased risk: Women with dense breasts have higher breast cancer risk
• Legislation: 38 states require density notification to patients

Supplemental screening options for dense breasts:

Automated Breast Ultrasound (ABUS):

• Handheld ultrasound: Traditional ultrasound performed by technologist
• Automated ultrasound: 3D ultrasound covering entire breast
• Benefits:
  • Finds additional cancers not seen on mammogram (2-4 per 1,000 women)
  • No radiation
  • Relatively inexpensive
  • Widely available
• Limitations:
  • Many false positives (benign findings that require biopsy)
  • Operator-dependent for handheld ultrasound
  • Not covered by all insurance for screening

Breast MRI:

• Most sensitive test: Detects 98% of breast cancers
• Indicated for:
  • High-risk women (BRCA carriers, strong family history)
  • Implant rupture evaluation
  • Cancer staging (extent of disease)
  • Neoadjuvant chemotherapy monitoring
• Screening dense breasts: Controversial—not routinely recommended for average-risk women with dense breasts alone
• Limitations:
  • Very expensive ($1,000-2,000)
  • Requires IV contrast
  • Higher false-positive rate
  • Limited availability
  • Requires lying still for 30-45 minutes

Contrast-enhanced mammography:

• Newer technology: Mammogram with iodinated contrast
• Benefits: Improved cancer detection, less expensive than MRI
• Growing availability: Becoming more widely available

Abbreviated MRI:

• Shorter, cheaper MRI: 10-minute protocol for screening
• Cost: About 50% less than full MRI
• Availability: Increasingly offered for dense breast screening

Breast MRI

Indications for breast MRI:

Screening (high-risk women):

• BRCA1/2 mutation carriers
• Lifetime risk >20% (based on family history models)
• Prior chest radiation (Hodgkin's lymphoma treatment)
• Li-Fraumeni syndrome, Cowden syndrome, other genetic syndromes
• Strong family history: Multiple first-degree relatives with breast cancer

Diagnostic evaluation:

• Implant rupture: Assessing silicone or saline implants
• Cancer staging: Determining extent of disease, additional tumors
• Neoadjuvant chemotherapy: Monitoring response to treatment
• Occult primary cancer: Cancer found in lymph nodes but not seen on mammogram/ultrasound
• Recurrence: Distinguishing scar from recurrence after lumpectomy

What to expect during breast MRI:

• IV contrast: Gadolinium injected through arm vein
• Prone position: Lying on stomach, breasts suspended through opening
• Scan time: 30-45 minutes
• Noise: Loud tapping and banging (ear protection provided)
• Claustrophobia: Can be an issue (breast coils are more confining than mammogram)
• No compression: Unlike mammography, no breast compression

Pelvic Ultrasound: First-Line Imaging

What pelvic ultrasound evaluates:

• Uterus: Fibroids, adenomyosis, endometrial abnormalities, uterine shape
• Ovaries: Cysts, masses, torsion, polycystic ovary syndrome (PCOS)
• Fallopian tubes: Hydrosalpinx (fluid-filled tubes), tubal masses
• Pelvic pain: Endometriosis, infection, adhesions
• Abnormal bleeding: Fibroids, polyps, endometrial hyperplasia, cancer
• Infertility: Anatomic evaluation, follicle monitoring

Types of pelvic ultrasound:

Transabdominal ultrasound:

• Full bladder required: Bladder acts as acoustic window
• Less detailed: Good for large masses and overall survey
• Comfort: No internal probe
• First choice: For children, women who haven't been sexually active

Transvaginal ultrasound:

• Higher resolution: Internal probe placed in vagina gets closer to pelvic organs
• Better detail: Superior for evaluating ovaries, endometrium, small masses
• Comfort: More detailed but more invasive
• Empty bladder: Preferred (unlike transabdominal)
• Not appropriate: For women who haven't been sexually active

Pelvic ultrasound preparation:

• Transabdominal: Drink 32 oz of water 1 hour before (don't urinate)
• Transvaginal: Empty bladder preferred
• Timing: May be scheduled during specific menstrual cycle phase depending on indication

Fibroid Imaging

Uterine fibroids (leiomyomas): Benign tumors of uterine muscle

Imaging options:

Ultrasound (first choice):

• Detects fibroids: Size, number, location
• Classifies location: Subserosal, intramural, submucosal
• Monitors growth: Follow-up imaging to assess changes
• Guides procedures: For fibroid treatments

MRI (more detailed):

• Precise mapping: Exact size, number, location of all fibroids
• Treatment planning: Before uterine fibroid embolization or myomectomy
• Distinguishes: Fibroids from adenomyosis (different conditions)
• Complex cases: When ultrasound is limited or surgery is being considered

Imaging findings:

• Submucosal: Beneath the uterine lining (cause bleeding, affect fertility)
• Intramural: Within the uterine wall (most common)
• Subserosal: On the outer surface of uterus (can cause pressure symptoms)
• Pedunculated: On a stalk (subserosal or submucosal)
• Degeneration: Fibroids outgrowing their blood supply (painful)

Endometriosis Imaging

Endometriosis: Endometrial tissue outside the uterus

Imaging challenges:

• Ultrasound: Often normal (even with severe endometriosis)
• MRI: Superior for detecting deep infiltrating endometriosis

MRI for endometriosis:

• Best modality: Detects 80-90% of deep infiltrating endometriosis
• Shows: Endometriomas (chocolate cysts), deep implants, adenomyosis
• Treatment planning: Maps disease before surgery
• Timing: Optimal in second half of menstrual cycle (days 15-20)

Ultrasound for endometriosis:

• Endometriomas: Characteristic appearance (ground-glass echogenicity)
• Deep endometriosis: May see nodules, but often normal
• Adenomyosis: Can be suggested on ultrasound

Ovarian Cyst and Mass Evaluation

Ovarian imaging findings:

Simple cyst (almost always benign):

• Thin smooth wall: No internal debris
• Anechoic: Fluid-filled, no echoes inside
• Enhanced through transmission: Sound waves pass through easily
• Management: Usually observation, especially if ＜5cm and premenopausal

Complex cyst (requires follow-up or intervention):

• Septations: Divisions within the cyst
• Solid components: Nodular areas within cyst
• Papillary projections: Solid bumps projecting into cyst
• Thickened walls or nodularity: Suspicious features
• Management: Follow-up imaging, surgical evaluation, or referral to gynecologic oncologist

Characterizing ovarian masses:

• Ultrasound first: Determines size, complexity, vascularity (Doppler)
• MRI: When ultrasound indeterminate, better characterizes complex masses
• CT: Rarely needed; used for cancer staging, surgical planning
• Tumor markers: CA-125 blood test (limited by false positives)

First Trimester Ultrasound

Dating ultrasound (6-12 weeks):

• Confirms pregnancy: Uterine (not ectopic)
• Determines due date: Based on crown-rump length (most accurate)
• Detects fetal heartbeat: Confirms viability
• Number of fetuses: Singleton vs. twins/triplets

Nuchal translucency (11-14 weeks):

• Down syndrome screening: Measures fluid at back of fetal neck
• First trimester screen: Combined with blood tests

Second Trimester Ultrasound

Anatomy survey (18-22 weeks):

• Detailed evaluation: All fetal organs and structures
• Fetal measurements: Growth assessment
• Placenta location: Rules out placenta previa
• Amniotic fluid: Assessing fluid volume
• Sex determination: If parents want to know

Third Trimester Ultrasound

Growth assessment (if indicated):

• Fetal size: Measuring abdomen, head, femur
• Amniotic fluid: Too much or too little fluid
• Placenta position: Confirming placenta location
• Fetal position: Breech vs. head-down

Pregnancy Imaging Safety

Radiation concerns:

• Ionizing radiation: X-rays and CT scans should be avoided when possible
• Ultrasound: Completely safe throughout pregnancy
• MRI: Safe after first trimester, no radiation
• CT abdomen/pelvis: Should only be performed when medically necessary

Common pregnancy imaging:

• Abdominal pain: Ultrasound first (ovarian torsion, appendicitis, uterine rupture)
• Vaginal bleeding: Ultrasound to assess placenta location, fetal status
• Kidney stone: Ultrasound first, CT if needed and medically necessary
• Pulmonary embolism: V/Q scan or CT (both involve radiation, V/Q preferred)

Abnormal Uterine Bleeding

Imaging workup:

• Premenopausal women: Transvaginal ultrasound first
• Postmenopausal women: Transvaginal ultrasound, possible endometrial biopsy
• What imaging looks for: Fibroids, polyps, endometrial thickness, cancer

Endometrial thickness:

• Premenopausal: Varies by menstrual cycle phase (up to 12-16mm normal)
• Postmenopausal: >4-5mm is abnormal (requires biopsy)

Pelvic Pain

Imaging based on suspected cause:

• Ovarian cyst: Transvaginal ultrasound
• Fibroids: Transvaginal ultrasound
• Endometriosis: MRI (ultrasound often normal)
• Pelvic inflammatory disease: Ultrasound (tubo-ovarian abscess, hydrosalpinx)
• Adenomyosis: Ultrasound or MRI

Infertility Evaluation

Imaging workup:

• Hysterosalpingography (HSG): X-ray with contrast to evaluate fallopian tubes
• Saline infusion sonohysterography: Ultrasound with saline to evaluate uterine cavity
• Pelvic ultrasound: Assess ovaries, uterus, follicles
• MRI: For suspected fibroids, endometriosis, congenital abnormalities

Ovarian Cancer Screening

Routine screening not recommended for average-risk women (no proven mortality benefit)

High-risk women (BRCA carriers, strong family history):

• Transvaginal ultrasound: Every 6-12 months
• CA-125 blood test: Every 6-12 months (controversial)
• Risk-reducing surgery: Removal of ovaries and fallopian tubes after childbearing

20s-30s

Baseline considerations:

• Breast imaging: Only if symptomatic (lump, pain, discharge)
• Pelvic imaging: For pain, irregular periods, infertility, or abnormal bleeding
• Pap smears: Cervical cancer screening (not imaging but related women's health)

40s

Breast cancer screening:

• Annual mammogram: Starting at age 40 (or earlier if high risk)
• Dense breast notification: May prompt supplemental screening discussion
• Breast awareness: Knowing what's normal for your breasts

Pelvic imaging:

• As clinically indicated: For bleeding, pain, masses
• Perimenopause: Fibroids, ovarian cysts become more common

50s

Breast cancer screening:

• Annual mammogram: Continue annually
• Consider 3D mammography: If available

Pelvic imaging:

• Postmenopausal bleeding: Immediate evaluation (ultrasound ± biopsy)
• Ovarian cysts: More concerning after menopause (often requires surgical evaluation)

60s and Beyond

Breast cancer screening:

• Continue annual mammogram: As long as in good health
• No upper age limit: If life expectancy >10 years

Pelvic imaging:

• Any bleeding: Urgent evaluation (endometrial cancer risk increases)
• Ovarian masses: Higher suspicion for malignancy

Do mammograms hurt?

Most women find mammograms uncomfortable but not severely painful. The breast compression:

• Lasts seconds: Each compression lasts 10-20 seconds
• Is necessary: Spreads tissue for better images and lower radiation dose
• Varying discomfort: More uncomfortable during menstruation (schedule 1-2 weeks after period)

Reducing discomfort:

• Schedule wisely: 1-2 weeks after your period when breasts are less tender
• Caffeine avoidance: Reducing caffeine for a week before may decrease breast tenderness
• Over-the-counter pain medication: Taking acetaminophen or ibuprofen an hour before may help
• Communication: Tell the technologist if you're uncomfortable—they may adjust compression

When should I start mammograms?

For average-risk women:

• ACR and ACOG: Start at 40 annually
• USPSTF: Start at 50 every 2 years
• ACS: Start at 45 (strongly recommend), 40-45 (choice)

Start earlier if:

• Family history of breast cancer (especially before menopause)
• BRCA gene mutation
• Prior chest radiation therapy
• Personal history of breast cancer or high-risk lesions

Discuss with your doctor: Your individual risk factors and values should guide the decision.

Do I need breast ultrasound if I have dense breasts?

Not automatically, but consider supplemental screening if:

• Dense breasts (heterogeneously dense or extremely dense)
• Additional risk factors: Family history, prior biopsies, other risk factors
• Your breast center recommends it: Many radiologists recommend screening ultrasound for dense breasts

Discuss pros and cons:

• Benefit: Finding additional cancers (2-4 per 1,000 women screened)
• Harms: False positives, additional biopsies, anxiety, cost
• Insurance: Not always covered for screening (varies by state and insurance)

Is pelvic ultrasound safe during pregnancy?

Yes. Ultrasound uses sound waves, not radiation, and is completely safe throughout pregnancy. It's the primary imaging modality for evaluating pregnancy complications, fetal anatomy, and gynecologic conditions during pregnancy.

Can I have a mammogram while breastfeeding?

Yes, but:

• Empty breasts first: Breastfeed or pump immediately before mammogram to reduce milk and improve images
• Mammogram is safe: No radiation to breast milk
• Lactation changes: Breast tissue is denser while breastfeeding, which may affect mammogram accuracy
• Ultrasound may be preferred: If you have a breast lump while breastfeeding

How accurate is ovarian ultrasound for detecting cancer?

Ovarian ultrasound characteristics can suggest benign vs. malignant:

• Most ovarian cysts are benign: Especially simple cysts ＜5cm in premenopausal women
• Suspicious features: Complex cysts with solid components, septations, papillary projections, increased blood flow on Doppler
• Risk of Malignancy Index (RMI): Scoring system based on ultrasound, menopausal status, and CA-125

No perfect test: Ultrasound cannot definitively distinguish all benign from malignant masses. Surgery is sometimes needed for definitive diagnosis.

1. Breast cancer screening with mammography should begin at age 40 for average-risk women (earlier for high-risk women).

2. Dense breasts are common (50% of women) and both increase breast cancer risk and mask cancers on mammograms.

3. Supplemental screening with breast ultrasound or MRI may be recommended for women with dense breasts or high risk.

4. Pelvic ultrasound is the first choice for evaluating gynecologic concerns—fibroids, ovarian cysts, pelvic pain, and abnormal bleeding—using no radiation.

5. Breast MRI is recommended for high-risk women (BRCA carriers, strong family history, prior chest radiation).

6. Pregnancy imaging: Ultrasound is completely safe; CT and X-rays should be avoided unless medically necessary.

7. Abnormal uterine bleeding evaluation begins with transvaginal ultrasound to assess for fibroids, polyps, and endometrial thickness.

8. Endometriosis is best evaluated with MRI, which can detect deep infiltrating endometriosis and adenomyosis better than ultrasound.

9. Ovarian cysts are common and usually benign; simple cysts in premenopausal women rarely require intervention.

10. Imaging recommendations vary by age: Screening mammograms from 40+, any postmenopausal bleeding requires urgent evaluation, and dense breasts may need supplemental screening.

Disclaimer: This guide provides general information about women's imaging. Always consult your healthcare provider for personalized screening and imaging recommendations based on your individual risk factors and medical history.

Last Updated: March 2026 Next Review: September 2026